Market capitalization | $60.61m |
Enterprise Value | $61.55m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 9.41 |
P/S ratio (TTM) P/S ratio | 9.27 |
P/B ratio (TTM) P/B ratio | 1.18 |
Revenue growth (TTM) Revenue growth | -93.33% |
Revenue (TTM) Revenue | $6.54m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
1 Analyst has issued a forecast Happiness Biotech Group Ltd:
1 Analyst has issued a forecast Happiness Biotech Group Ltd:
Mar '24 |
+/-
%
|
||
Revenue | 6.54 6.54 |
93%
93%
|
|
Gross Profit | -0.35 -0.35 |
107%
107%
|
|
EBITDA | -12 -12 |
79%
79%
|
EBIT (Operating Income) EBIT | -11 -11 |
82%
82%
|
Net Profit | -18 -18 |
75%
75%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Happiness Biotech Group Ltd. is a nutraceutical and dietary supplements producer, which engages in the research, development, manufacturing, marketing, and sales of a variety of products made from herbal and animal extracts. The firm's products include lucidum spore powder; cordyceps mycelia; ijiao solution; and American ginseng. It operates under the brand name Happiness. The company was founded on February 9, 2018 and is headquartered in Nanping City, China.
Head office | Cayman Islands |
CEO | Xue Wang |
Employees | 11 |
Founded | 2018 |
Website | www.pavs.ai |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.